News – Page 141 – Endpoints News

Zealand rides obesity wave with $1B raise to advance amylin drug and look for a partner

11 months ago

Lyell reports patient death, early responses in solid tumor CAR-T trial

11 months ago

Arrowhead shelves one cardiometabolic drug candidate, focuses on another

11 months ago

Lilly becomes the latest pharma to tap OpenAI for help, this time for antibiotic work

11 months ago

Can CRISPR be given twice? Small study from Intellia suggests it can

11 months ago

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

11 months ago

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

11 months ago

Teva to pay $750M to resolve Israel tax disputes

11 months ago

Wave Life Sciences touts Huntington's disease win in Phase 1b/2a trial

11 months ago

Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials

11 months ago

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

11 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

11 months ago

Exclusive: Cityblock Health investors buy employee shares in tender offer

11 months ago

FDA again rejects AbbVie's continuous infusion therapy for Parkinson's

11 months ago

J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded

11 months ago

AstraZeneca’s Imfinzi aces Phase 3 test in bladder cancer, fails another in lung cancer

11 months ago

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi

11 months ago

Ex-Meta scientists launch EvolutionaryScale with $142M seed round, unveiling next-gen AI model for protein design

11 months ago

Can mRNA be harnessed for gene insertion? Moderna's former chief medical officer has $82M to find out

11 months ago

Grail prepares for public debut, and challenges of going independent, after spinoff from Illumina

11 months ago

Korea-based Bridge Biotherapeutics closes Boston office

11 months ago

House committee presses FDA on signs of inconsistent inspections in China and India

11 months ago

Merck KGaA's bet on head and neck cancer drug from Debiopharm ends in Phase 3 failure

11 months ago

Novo Nordisk budgets $4.1B for new US manufacturing site as it abandons plans for Irish build

11 months ago

First page Previous page 138 139 140141142 143 144 Next page Last page